| Drugs prescribed |
Group 1998(N=307) |
Group 2006(N=236) |
P |
| NRTIs – no (%) |
|
|
<0.001 |
| - Thymidine analogues |
288 (93.8) |
85 (36.2) |
|
| - other analogues |
17 (5.6) |
150 (63.6) |
|
| NNRTIs – no (%) |
|
|
<0.001 |
| -EFV |
5 (1.6) |
71 (30.1) |
|
| -NVP |
29 (9.4) |
12 (5.1) |
|
| PIs – no (%) |
|
|
<0.001 |
| -boosted PIs |
6 (1.9) |
129 (54.7) |
|
| -unboosted PIs |
255 (83.1) |
22 (9.3) |
|
NRTI Nucleoside Reverse Transcriptase Inhibitor; NNRTI Non Nucleoside
Reverse Transcriptase Inhibitor; PI ProteaseIinhibitor; NVP Nevirapine; EFV
Efavirenz |
